SCHEMBL8494353

SCHEMBL8494353

N#Cc1ccc(CNC(=O)c2cccc3cc(C(=O)O)ccc23)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 4/20 0.55
HDAC1 Q13547 2/20 0.55
HDAC3 O15379 1/20 0.55
HDAC4 P56524 1/20 0.55
HDAC7 Q8WUI4 1/20 0.55
HDAC10 Q969S8 1/20 0.55
HDAC11 Q96DB2 1/20 0.55
HDAC8 Q9BY41 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55
HDAC9 Q9UKV0 1/20 0.55
HDAC5 Q9UQL6 1/20 0.55
PTPN1 P18031 1/20 0.52
NR1H4 Q96RI1 3/20 0.51
EPHX2 P34913 2/20 0.49
AKR1B1 P15121 1/20 0.46
APEX1 P27695 1/20 0.46
MAOA P21397 1/20 0.45
KLKB1 P03952 1/20 0.45
KLK1 P06870 1/20 0.45
KDM1A O60341 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1320296 0.85 HDAC2 (0.50) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL8525436 0.85 HDAC2 (0.50) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL8525574 0.84 AKR1B1 (0.48) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL8524189 0.81 AKR1B1 (0.48) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL8525059 0.81 HDAC2 (0.46) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL18132545 0.78 APEX1 (0.77) HDAC7EPHX2AKR1B1APEX1MAOA
SCHEMBL20764583 0.77 EPHX2 (0.72) HDAC2HDAC1HDAC8HDAC6NR1H4
SCHEMBL8524730 0.76 CA12 (0.42) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL1110102 0.75 TUBB (0.46) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL8489621 0.74 EGLN1 (0.46) HDAC2HDAC1HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999029670-A2 AMINOCARBONYLTETRALIN AND DIHYDRONAPHTALENE DERIVATES AS THROMBIN INHIBITORS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-06-17 WO disclosed